238 related articles for article (PubMed ID: 19439667)
1. Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease.
Jeong JW; Lee HS; Lee KY; White LD; Broaddus RR; Zhang YW; Vande Woude GF; Giudice LC; Young SL; Lessey BA; Tsai SY; Lydon JP; DeMayo FJ
Proc Natl Acad Sci U S A; 2009 May; 106(21):8677-82. PubMed ID: 19439667
[TBL] [Abstract][Full Text] [Related]
2. Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer.
Kim TH; Lee DK; Cho SN; Orvis GD; Behringer RR; Lydon JP; Ku BJ; McCampbell AS; Broaddus RR; Jeong JW
Cancer Res; 2013 Aug; 73(16):5090-9. PubMed ID: 23811943
[TBL] [Abstract][Full Text] [Related]
3. MIG-6 suppresses endometrial epithelial cell proliferation by inhibiting phospho-AKT.
Yoo JY; Kang HB; Broaddus RR; Risinger JI; Choi KC; Kim TH
BMC Cancer; 2018 May; 18(1):605. PubMed ID: 29843645
[TBL] [Abstract][Full Text] [Related]
4. A calcium-dependent phospholipase A2 (cPLA2) expression is regulated by MIG-6 during endometrial tumorigenesis.
Teasley HE; Jeong MP; Kim TH
Biochem Biophys Res Commun; 2019 Mar; 511(1):129-134. PubMed ID: 30773264
[TBL] [Abstract][Full Text] [Related]
5. MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial cells.
Yoo JY; Yang WS; Lee JH; Kim BG; Broaddus RR; Lim JM; Kim TH; Jeong JW
Oncogene; 2018 Jan; 37(2):255-262. PubMed ID: 28925396
[TBL] [Abstract][Full Text] [Related]
6. MIG-6 Is Critical for Progesterone Responsiveness in Human Complex Atypical Hyperplasia and Early-Stage Endometrial Cancer.
Jeong O; Broaddus RR; Lessey BA; Risinger JI; Hunter MI; Kim TH
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498921
[TBL] [Abstract][Full Text] [Related]
7. Mig-6 regulates endometrial genes involved in cell cycle and progesterone signaling.
Yoo JY; Kim TH; Lee JH; Dunwoodie SL; Ku BJ; Jeong JW
Biochem Biophys Res Commun; 2015 Jul; 462(4):409-14. PubMed ID: 25976672
[TBL] [Abstract][Full Text] [Related]
8. Mig-6 Mouse Model of Endometrial Cancer.
Kim TH; Yoo JY; Jeong JW
Adv Exp Med Biol; 2017; 943():243-259. PubMed ID: 27910070
[TBL] [Abstract][Full Text] [Related]
9. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers.
Balmer NN; Richer JK; Spoelstra NS; Torkko KC; Lyle PL; Singh M
Mod Pathol; 2006 Dec; 19(12):1593-605. PubMed ID: 16980945
[TBL] [Abstract][Full Text] [Related]
10. The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression.
Kim TH; Franco HL; Jung SY; Qin J; Broaddus RR; Lydon JP; Jeong JW
Oncogene; 2010 Jul; 29(26):3770-80. PubMed ID: 20418913
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of mitogen-inducible gene 6 triggers antitumor effect and attenuates progesterone resistance in endometrial carcinoma cells.
Xu W; Zhu S; Zhou Y; Jin Y; Dai H; Wang X
Cancer Gene Ther; 2015 Nov; 22(11):536-41. PubMed ID: 26450625
[TBL] [Abstract][Full Text] [Related]
12. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression.
Uchikawa J; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Oka K; Konishi I
Cancer; 2003 Nov; 98(10):2207-13. PubMed ID: 14601091
[TBL] [Abstract][Full Text] [Related]
13. The p160 steroid receptor coactivator 2, SRC-2, regulates murine endometrial function and regulates progesterone-independent and -dependent gene expression.
Jeong JW; Lee KY; Han SJ; Aronow BJ; Lydon JP; O'Malley BW; DeMayo FJ
Endocrinology; 2007 Sep; 148(9):4238-50. PubMed ID: 17556502
[TBL] [Abstract][Full Text] [Related]
14. Endometrial progesterone resistance and PCOS.
Li X; Feng Y; Lin JF; Billig H; Shao R
J Biomed Sci; 2014 Jan; 21(1):2. PubMed ID: 24405633
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer.
Deng L; Broaddus RR; McCampbell A; Shipley GL; Loose DS; Stancel GM; Pickar JH; Davies PJ
Clin Cancer Res; 2005 Dec; 11(23):8258-64. PubMed ID: 16322283
[TBL] [Abstract][Full Text] [Related]
16. Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
Kim TH; Yoo JY; Kim HI; Gilbert J; Ku BJ; Li J; Mills GB; Broaddus RR; Lydon JP; Lim JM; Yoon HG; Jeong JW
Cancer Res; 2014 Dec; 74(24):7371-82. PubMed ID: 25377472
[TBL] [Abstract][Full Text] [Related]
17. Panobinostat Enhances Growth Suppressive Effects of Progestin on Endometrial Carcinoma by Increasing Progesterone Receptor and Mitogen-Inducible Gene-6.
Ando H; Miyamoto T; Kashima H; Higuchi S; Ida K; Mvunta DH; Shiozawa T
Horm Cancer; 2017 Aug; 8(4):257-267. PubMed ID: 28516379
[TBL] [Abstract][Full Text] [Related]
18. A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells.
Kommagani R; Szwarc MM; Kovanci E; Creighton CJ; O'Malley BW; Demayo FJ; Lydon JP
Biol Reprod; 2014 Apr; 90(4):75. PubMed ID: 24571987
[TBL] [Abstract][Full Text] [Related]
19. Progesterone receptor expression and proliferative activity in uterine tumours of pet rabbits.
Vinci A; Bacci B; Benazzi C; Caldin M; Sarli G
J Comp Pathol; 2010 May; 142(4):323-7. PubMed ID: 20096851
[TBL] [Abstract][Full Text] [Related]
20. Steroid hormone intervenes in the endometrial tumorigenesis of pten ablation.
Kim HI; Kim TH; Lim JM; Jeong JW
J Cancer Prev; 2013 Dec; 18(4):313-21. PubMed ID: 25337560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
